State Street SPDR S&P Pharmaceuticals ETF XPH
Set alert
64.80 USD -0.38 -0.58%
At close · Oct 30
64.80 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
64.44 Day range 65.71
47.60 52-week range 74.35
- YTD
- +15.69%
- 1 year
- +31.41%
- Open
- 65.32
- Prev close
- 65.18
- Mkt cap
- 262.86M
- Vol
- 230.63K
- Avg vol
- 169.18K
- EPS
- 3.78
- P/E
- 17.13
- Div yield
- 0.00%
More statistics
- Low
- 64.44
- High
- 65.71
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 45.94
- 200-d avg
- 42.92
1M chart
Signals (7)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 3 weeks ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 15.63
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 45.94
- 200-day average
- 42.92
About State Street SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- Which Healthcare ETF Is the Better Buy: State Street's Pharma XPH or Simplify's Mission-Driven PINK?
- Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
- XPH: Healthcare Sector Dashboard For October
- Better Pharma ETF: iShares IHE vs. State Street XPH
- Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
- Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
- Execution of Pharma Tariffs Brings These ETFs Into Focus
- SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sees Large Volume Increase – Still a Buy?
- Integrated Wealth Concepts LLC Buys Shares of 48,874 SPDR S&P Pharmaceuticals ETF $XPH
Your note
Sign in to keep a note on XPH — it syncs with the Stock Master app.